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Introduction
There is increasing evidence that Ca 2+ overload and excito toxicity are central players in a wide variety of neurological diseases, including stroke and Parkinson's and Alzheimer's diseases (Orrenius et al., 2003; Dong et al., 2006) . Glutamate receptors and voltagegated Ca 2+ channels (VGCCs) are the main sources of Ca 2+ influx in neurons and contribute significantly to pathological Ca 2+ elevations. To prevent Ca 2+ induced damage, neurons have evolved a variety of feedback pathways that limit Ca 2+ influx during periods of excessive extracellular glutamate or intense electrical activity (Stotz and Zamponi, 2001; Budde et al., 2002; Davis and Linn, 2003; Green et al., 2007; Jarvis and Zamponi, 2007) . Among the most important of these feed back pathways is the internalization of Ca 2+ channels, which are the main sources of Ca 2+ in excitable cells. Glutamate receptors are internalized after tetanic stimulation or bath treatment with glutamate (Derkach et al., 2007; Lau and Zukin, 2007) , but it is not known whether this type of stimulation also causes internal ization of VGCCs.
VGCCs are classified according to their biophysical prop erties and susceptibility to pharmacological blockers. Ltype VGCCs (LTCs) have a large persistent current that makes them a large source of intracellular Ca 2+ (Tsien et al., 1988; Catterall, 2000) . Ca V 1.2 is the most abundant LTC in the mammalian brain and is expressed in the spines, dendritic shafts, and cell bodies of most neurons in the brain. Several functions have been described for Ca V 1.2, including roles in gene expression, den dritic arborization, survival, and synaptic plasticity (Westenbroek et al., 1990; Hell et al., 1993; Catterall, 2000; CalinJageman and Lee, 2008) . Ca 2+ influx through Ca V 1.2 also contributes to neuronal death during ischemia, and LTC blockers have been shown to decrease neuronal death in models of stroke (Korenkov et al., 2000; Schurr, 2004) .
The number of LTCs on the cell surface is altered under many physiological and pathological conditions. During aging and in Alzheimer's disease, there is an increase in the number of cell surface LTCs that is associated with neuronal dysfunction (Disterhoft et al., 1994; Haase et al., 1996; V oltage-gated Ca 2+ channels (VGCCs) play a key role in neuronal signaling but can also contribute to cellular dysfunction and death under pathological conditions such as stroke and neurodegenerative diseases. We report that activation of N-methyl-d-aspartic acid receptors causes internalization and degradation of Ca V 1.2 channels, resulting in decreased Ca 2+ entry and reduced toxicity. Ca V 1.2 internalization and degradation requires binding to phosphatidylinositol 3-phosphate 5-kinase (PIKfyve), a lipid kinase which generates phosphatidylinositol (3,5)-bisphosphate (PtdIns(3,5)P 2 ) and regulates endosome and lysosome function. Sustained activation of glutamate receptors recruits PIKfyve to Ca V 1.2 channels, increases cellular levels of PtdIns(3,5)P 2 , and promotes targeting of Ca V 1.2 to lysosomes. Knockdown of PIKfyve prevents Ca V 1.2 degradation and increases neuronal susceptibility to excitotoxicity. These experiments identify a novel mechanism by which neurons are protected from excitotoxicity and provide a possible explanation for neuronal death in diseases caused by mutations that affect PtdIns(3,5)P 2 regulation.
Ca 2+ influx through Nmethyldaspartic acid (NMDA) receptors and VGCCs and leads to Ca 2+ induced toxicity (Schurr, 2004) . Although it is known that activation of glutamate receptors causes internalization of AMPA and NMDA receptors (Derkach et al., 2007; Lau and Zukin, 2007) , little is known about the effect of excess glutamate on the cell surface expression of VGCCs. To determine whether glutamate receptors regulate the number of Ca V 1.2 channels on the cell surface, we used an assay that we previously developed to measure the surface levels of Ca V 1.2 channels in primary neurons . We introduced Ca V 1.2 channels containing both an intra cellular YFP and an extracellular HA epitope into primary cortical neurons and used antiHA antibodies to label channels on the cell surface. Because the HA antibodies do not cross the cell membrane, the ratio of the antiHA to YFP fluorescence provides a quantitative measurement of the proportion of chan nels on the plasma membrane.
Stimulation with 50 µM glutamate led to a 60% decrease in the proportion of Ca V 1.2 channels on the cell surface, indicat ing that a significant proportion of Ca V 1.2 channels are internal ized relatively rapidly by a large dose of glutamate (Fig. 1, A and B) . To provide independent evidence that activation of glutamate receptors causes loss of cell surface Ca V 1.2 channels, we used Ca 2+ imaging to measure Ca 2+ influx in neurons before and after treatment with high concentrations of glutamate. Treatment with 50 µM glutamate for 10 min caused a significant decrease in the intracellular Ca 2+ rise induced by depolarization. This decrease could be observed both at the population level and in single cells (Fig. 1 C) . Together, these experiments sug gest that relatively prolonged activation of glutamate receptors causes loss of Ca V 1.2 channels on the cell membrane.
Because prolonged treatment with glutamate can cause excitotoxicity in neurons, we next investigated whether loss of Ca V 1.2 channels was correlated with cell death in neurons. We treated neurons with 10, 50, or 100 µM glutamate for 3, 10, or 30 min or 10 h and measured cell death 10 h later by counting pyknotic nuclei, measuring MAP2 levels in dendrites, or using TUNEL staining (Fig. S1 ). Although treatment with 50 or 100 µM glutamate for 30 min or 10 h caused substantial apop totic cell death, stimulation with 50 µM glutamate for 10 min (conditions which cause channel internalization) did not lead to cell death. This suggests that Ca V 1.2 internalization is not correlated with cell death and therefore is more likely to be a cellular response to a potentially cytotoxic stimulus.
In a previous study, we found that stimulation of neurons using relatively mild depolarizing stimuli to activate Ca V 1.2 channels caused a reversible loss of cell surface Ca V 1.2 chan nels . Under these conditions, Ca V 1.2 chan nels are returned to the membrane rapidly after restoration of the resting membrane potential. To investigate whether activa tion of glutamate receptors also led to reversible loss of Ca V 1.2 channels from the cell membrane, we stimulated neurons with 50 µM glutamate for 10 min and then returned the cells to rest ing conditions for 20 min before measuring cell surface chan nels. In contrast to our previous findings , we observed no recovery of Ca V 1.2 channels on the cell mem brane 20 min after treatment with 50 µM glutamate (Fig. 1 D) , 1996; Coon et al., 1999) . Studies in animals and humans have reported that LTC blockers can improve performance on mem ory tasks (for review see Thibault et al., 2007) . In addition, a developmentally regulated increase in Ca V 1.2 levels could lead to cell death in Parkinson's disease (Day et al., 2006; Chan et al., 2007) . However, despite the importance of LTCs in neuronal pathology, the mechanisms that control their expression and trafficking are not well understood.
Phosphatidylinositol (3,5)bisphosphate (PtdIns(3,5)P 2 ) is a rare phospholipid that is found in endosomal membranes and is generated by the activity of a lipid kinase called phosphati dylinositol 3phosphate 5kinase (PIKfyve; mammals) or Fab1 (yeast; Michell et al., 2006) . PIKfyve/Fab1 is critically impor tant for the regulation of membrane trafficking and for the func tion of endosomes and lysosomes. Fab1 mutants have enlarged vacuoles and defects in multivesicular body invagination and vacuole acidification (Gary et al., 1998; Odorizzi et al., 1998; Efe et al., 2005) . Genetic disruption of Fab1 is lethal in model organisms, and inhibition of PIKfyve leads to the enlargement of endosomes and formation of vacuoles in cells in culture (Ikonomov et al., 2001; Nicot et al., 2006; Rusten et al., 2006; Rutherford et al., 2006) .
Recently, it has been shown that mutations that alter the production of PtdIns(3,5)P 2 cause severe neuronal defects in both mice and in humans. Mutations in mouse Fig4 and Vac14, two proteins which regulate PIKfyve (Duex et al., 2006; Sbrissa et al., 2007; Botelho et al., 2008) , reduce PtdIns(3,5)P 2 levels and lead to ataxia and neuronal death Zhang et al., 2007) . In addition, mutations in other proteins that control PtdIns(3,5)P 2 levels cause neuronal and muscular diseases, in cluding myotubular myopathy, amyotrophic lateral sclerosis, and CharcotMarieTooth disease (Nicot and Laporte, 2008) . This raises the question of why, despite the ubiquitous produc tion of PtdIns(3,5)P 2 in cells, mutations in this pathway prefer entially affect excitable cells like neurons and myocytes.
In this study, we report that sustained glutamate exposure causes internalization and degradation of Ca V 1.2 in cortical neurons. Using a proteomic screen, we identify PIKfyve as a Ca V 1.2binding protein, and we show that this protein binds to Ca V 1.2 upon activation of glutamate receptors. PIKfyve is re quired for both internalization and degradation of the channel, and loss of PIKfyve increases the susceptibility of neurons to cell death in response to activation of glutamate receptors. Our study suggests that PIKfyvedependent channel degradation is essential to prevent Ca 2+ induced toxicity in neurons. These experiments provide a direct link between Ca 2+ signaling and PIKfyve and help to explain why defects in PtdIns(3,5)P 2 sig naling are deleterious to cells that are susceptible to excitotoxicity such as neurons and myocytes.
Results
Glutamate stimulation promotes Ca V 1.2 internalization and degradation Ischemia and stroke cause neuronal death by triggering excess release of glutamate into the extracellular space, which activates free media (Fig. 1 H) ] i rise that was significantly greater than treatment with 10 µM glutamate, 67 mM KCl, or 2 µg/ml ionomycin (Fig. 2 A) . To determine whether Ca 2+ influx was required for glutamate dependent Ca V 1.2 degradation, we stimulated cells with 50 µM glutamate in media with reduced extracellular Ca 2+ and found that this completely prevented Ca V 1.2 degradation (Fig. 2 B) . This indicates that Ca 2+ influx across the membrane is required for this process.
Glutamate stimulation elevates [Ca 2+ ] i by a variety of mech anisms, including activation of Ca 2+ permeable AMPA and NMDA suggesting that activation of glutamate receptors leads to a per manent loss of Ca V 1.2 channels on the cell surface.
To determine whether the loss of Ca V 1.2 from the cell membrane was caused by channel degradation, we measured Ca V 1.2 levels in neurons either by Western blotting or by immunofluorescence. We stimulated neurons with 50 µM gluta mate and used SDSPAGE and antiCa V 1.2 antibodies to detect endogenous Ca V 1.2 channels (Fig. S2 , A-C). We found that this treatment caused a reproducible decrease in the levels of Ca V 1.2 relative to a glyceraldehyde3phosphate dehydrogenase (GAPDH) internal control ( Fig. 1 E) , suggesting that Ca V 1.2 was degraded after activation of glutamate receptors. To pro vide further evidence of glutamateinduced Ca V 1.2 degradation, we used immunocytochemistry to detect Ca V 1.2 channels in cultures of neurons before and after treatment with 50 µM glutamate for 10 min. Glutamate caused a 35% loss of Ca V 1.2 immunoreactivity from the dendrites and a redistribution of the channel to a region around the cell nucleus (Fig. 1, F and G; and Fig. S2 D) . This decrease in the levels of the endogenous channel was not reversed by a 20min incubation in glutamate in Ca V 1.2 channels (Fig. 3 C) . Together, these data suggest that lysosomes play a central role in Ca V 1.2 channel degrada tion in neurons.
To provide further evidence for the importance of lyso somes in the degradation of Ca V 1.2, we investigated whether treatment of neurons with glutamate caused relocalization of Ca 2+ channels to lysosomal compartments. We introduced a FlagMyc-labeled Ca V 1.2 channel (FlagMycCa V 1.2) and a GFP fusion protein of the lysosomalassociated membrane protein (LAMP; LAMPGFP) into neurons (Fig. S3 A) . Treatment with glutamate caused a significant increase in the colocalization of Ca V 1.2 and LAMPGFP in neuronal dendrites (Fig. 3 D) , sug gesting that the channels are targeted to lysosomes by activation of glutamate receptors.
PIKfyve associates with Ca V 1.2
To provide further insight into the mechanisms that underlie Ca V 1.2 internalization and degradation, we used a proteomic approach to identify Ca V 1.2binding proteins. We expressed GST fusion proteins of the intracellular domains of Ca V 1.2 in Neuro2A neuroblastoma cells, immunoprecipitated the proteins, and used multidimensional mass spectrometry to identify associ ated proteins. GSTYFP was immunoprecipitated and analyzed in parallel as control for nonspecific protein binding. We repeated receptors, metabotropic glutamate receptors, and indirect acti vation of VGCCs. To examine which of these pathways is responsible for Ca V 1.2 degradation, we treated neurons with 50 µM glutamate in the presence of NBQX, MK801, or DLAP3 to block AMPA, NMDA, or metabotropic glutamate receptors, re spectively. Treatment with NBQX and DLAP3 had no effect on Ca V 1.2 degradation, but treatment with MK801 prevented loss of Ca V 1.2 from dendrites ( Fig. 2 , C and D), indicating that Ca V 1.2 degradation depends on NMDA receptors. This is in agreement with a previous study of loss of LTC currents in neu rons treated with NMDA (Davis and Linn, 2003) .
Glutamate-induced Ca V 1.2 degradation occurs via lysosomes
Glutamatetriggered Ca V 1.2 degradation could occur either via the lysosomal or the proteosomal pathways. To determine which pathways regulate channel degradation, we treated cells with the lysosomal inhibitors bafilomycin and chloroquine or with the proteosomal inhibitor lactacystin. Both bafilomycin and chloro quine significantly inhibited glutamateinduced Ca V 1.2 degra dation, whereas lactacystin had no significant effect (Fig. 3 A) . In addition, NH 4 Cl, which prevents lysosomal acidification, caused a large increase in the number of Ca V 1.2 channels on the cell surface (Fig. 3 B) and reversed the glutamateinduced decrease with glutamate, Ca V 1.2 (Fig. 4 J) was reproducibly coimmuno precipitated with PIKfyve. These data argue that endogenous Ca V 1.2 associates with endogenous PIKfyve and, further, that this occurs in response to activation of glutamate receptors.
Activation of glutamate receptors increases PtdIns(3,5)P 2 levels
The inducible interaction of PIKfyve with Ca V 1.2 under condi tions of excitotoxic stress suggested that PIKfyve could be acti vated by glutamate receptors. To study this question, we made an intracellular sensor for PtdIns(3,5)P 2 , which is the main product of PIKfyve in cells. We made a fusion protein of GFP and two copies of the GRAM domain from the phosphatase myotubularin (MTM1; Fig. 5 A) , which binds to PtdIns(3,5)P 2 (Tsujita et al., 2004) . We introduced this protein into neurons and, upon treatment with 50 µM glutamate, observed a marked relocalization from the cytoplasm and the nucleus to a peri nuclear region (Fig. 5, B and C) . This change in localization was not observed in cells expressing GFP alone, suggesting that it is specific to the GRAMcontaining protein. The change in GFP GRAM localization was only observed in neurons treated with 50 µM glutamate but not with glutamate in the presence of EGTA, elevated KCl, or ionomycin, indicating that this event occurs only under the conditions that lead to Ca V 1.2 degrada tion (Fig. 5 D) .
The perinuclear localization of GFPGRAM after gluta mate treatment was very similar to that of lysosomes and late endosomes, so we explored whether GFPGRAM relocalizes to these compartments after activation of glutamate receptors. We coexpressed in neurons GFPGRAM and the lysosome marker LAMPCherry and observed a small increase in the colocaliza tion of the two proteins after treatment with glutamate ( Fig. S3 E) . This indicates that PtdIns(3,5)P 2 is generated in endosomal compartments in response to glutamate receptor activation.
To provide independent evidence that activation of gluta mate receptors leads to an increase in PtdIns(3,5)P 2 in neurons, we used a monoclonal antibody to detect PtdIns(3,5)P 2 . This anti body is relatively specific for PtdIns(3,5)P 2 , as determined by its ability to detect a decrease in PtdIns(3,5)P 2 levels in knock outs of ppk3, the Caenorhabditis elegans homologue of PIKfyve (Nicot et al., 2006) . Treatment of neurons with 50 µM glutamate resulted in an increase in antiPtdIns(3,5)P 2 fluores cence, which is consistent with our earlier finding (Fig. 5 B) that glutamate leads to relocalization of the GFPGRAM domain (Fig. 5, E and F) . Together, these results provide evidence that acti vation of glutamate receptors leads to an increase in PtdIns(3,5)P 2 levels in neurons.
We next asked whether the increase of PtdIns(3,5)P 2 trig gered by activation of glutamate receptors depends on PIKfyve activity. We made short hairpin RNAs (shRNAs) that target PIKfyve (shPIKfyve) and two PIKfyve constructs that contain silent mutations in the region recognized by the shRNA that could be the experiment five times and generated a score for each Ca V 1.2 interacting protein that reflected the number of times that the protein bound to Ca V 1.2 relative to YFP (Table S1 ). One of the main proteins that associated with the cytoplasmic C terminus of Ca V 1.2 was PIKfyve, a lipid kinase which is localized in early endosomes (Fig. S3 , B and C) and controls endosomal and lysosomal trafficking. Because Ca V 1.2 is degraded in lysosomes in response to glutamate stimulation, we investigated whether PIKfyve has a role in regulating this process.
To verify that Ca V 1.2 interacts with PIKfyve in cells, we in troduced MycPIKfyve and FlagCa V 1.2 expression plasmids into HEK 293T cells, lysed the cells, and immunoprecipitated the chan nel using antiFlag or antiMyc antibodies. Immunoprecipitation of the fulllength channel (Fig. 4 C) or of the cytoplasmic C termi nus of the channel (Fig. 4 A) resulted in coimmunoprecipitation of fulllength PIKfyve. Conversely, immunoprecipitation of PIKfyve caused coimmunoprecipitation of the Ca V 1.2 C terminus (Fig. 4 B) . We next expressed GFPPIKfyve and the Ca V 1.2 C terminus in HEK 293T cells. Expression of the Ca V 1.2 C terminus caused GFP PIKfyve to form large perinuclear aggregates, providing additional evidence that these two proteins interact in cells (Fig. S3 D) .
We then used deletion analysis to map the domains of PIKfyve and Ca V 1.2 that interact with each other. We sub divided PIKfyve into five fragments (Fig. 4 D) , expressed them in HEK 293T cells, and tested their ability to interact using coimmunoprecipitation assays. The two Nterminal fragments of PIKfyve did not associate with the C terminus of Ca V 1.2, but the three Cterminal fragments all interacted with this channel (Fig. 4, E and F) . We also subdivided the C terminus of Ca V 1.2 into five fragments and tested the association of these fragments with fulllength PIKfyve (Fig. 4 G) . We found that a domain composed of aa 1,709-1,808 of Ca V 1.2 (CT2) interacted with fulllength PIKfyve, whereas other regions did not (Fig. 4 H) . Expression of this CT2 fragment and the fragment immediately terminal to it (aa 1,809-1,928 or CT3) caused GFPPIKfyve to form perinuclear aggregates that were identical to those formed with the full C terminus of Ca V 1.2 (Fig. 4 I) . Together, these re sults suggest that aa 1,709-1,808 of Ca V 1.2 and the Cterminal fragment of PIKfyve are required for the interaction of these two proteins. The region from aa 1,709-1,808 is highly conserved in LTCs across various species, suggesting that it is likely to define a motif that is important for channel function. Although the na ture of these proteins made it impossible to purify them from bac teria to test for a direct interaction, our data are consistent with a direct interaction between the Cterminal domains of Ca V 1.2 and PIKfyve.
We next investigated whether Ca V 1.2 interacts with PIKfyve in a glutamatedependent manner. We used antiPIKfyve anti bodies to immunoprecipitate PIKfyve from cultured neurons before and after treatment with glutamate and used anti Ca V 1.2 to detect the channel by Western blotting. Ca V 1.2 did not associate with PIKfyve in resting cells, but in neurons stimulated Fig. 2 A (n = 60 cells; 300 ROIs; mean ± SEM; *, P < 0.001 by one-way MTM1, which dephosphorylates PtdIns(3,5)P 2 at the 3 position, and measured dendritic Ca V 1.2 levels in neurons. Expression of MTM1 reduced glutamateinduced Ca V 1.2 degradation in dendrites (Fig. S5, A and B) , providing additional evidence that PIKfyve and PtdInd(3,5)P 2 help mediate Ca V 1.2 degradation.
We next investigated whether the interaction of PIKfyve with the C terminus of Ca V 1.2 was important for glutamate dependent Ca V 1.2 degradation. We generated a MycCa V 1.2 channel that lacks the Cterminal PIKfyvebinding site (Ca V 1.2 CT), introduced it into neurons, and measured its degradation after activation of glutamate receptors. Although the wildtype channels were efficiently degraded by activation of glutamate receptors, the levels of Ca V 1.2 CT channels were not signifi cantly reduced (Fig. 6, E and F) , suggesting that binding of Ca V 1.2 to PIKfyve is required for Ca V 1.2 degradation in response to the activation of glutamate receptors.
Finally, we tested whether PIKfyve regulates the targeting of Ca V 1.2 channels to lysosomes after activation of glutamate receptors. We introduced LAMPGFP and MycCa V 1.2 into neu rons along with shPIKfyve or shScrambled constructs and then treated cells with glutamate. We measured the colocalization of Ca V 1.2 and LAMP by calculating the coefficient of correlation between Ca V 1.2 and LAMP in cells. Treatment with glutamate caused a loss of diffuse Ca V 1.2 staining and the appearance of MycCa V 1.2 puncta, some of which colocalized with LAMP GFP, giving rise to an increase in the coefficient of correlation between the two images. Knockdown of PIKfyve substantially reduced the colocalization of Ca V 1.2 and LAMP after activation of glutamate receptors (Fig. 6 G) , supporting the idea that Ca V 1.2 channels are trafficked to lysosomes after treatment with glutamate in a manner that depends on PIKfyve.
PIKfyve protects neurons against excitotoxic cell death
Under conditions of stroke and anoxia, glutamate is a potent excitotoxic agent that acts by increasing intracellular Ca 2+ lev els both through NMDA receptors and through LTCs (Schurr, 2004) . We initially characterized the contribution of different Ca 2+ channels to glutamatetriggered excitotoxicity in our cells by treating neurons for 30 min with 50 µM glutamate in the presence of blockers for NMDA receptors (MK801), AMPA receptors (NBQX), LTCs (nimodipine), P/Qtype VGCCs (aga toxin IVA), Ntype VGCCs (conotoxin GVIA), and Rtype VGCCs (SNX482) and measuring cell death 10 h later (Fig. 7,  A and B) . As expected, the NMDA receptor MK801 blocked 80% of the cell death, the AMPA receptors and LTC blockers reduced cell death 25%, and the other channel blockers had essentially no effect on glutamateinduced toxicity. This indi cates that although NMDA receptors are the primary triggers of excitotoxicity, both LTCs and AMPA receptors also play a role in this process. (Fig. S4 A) . In ad dition, shPIKfyve caused a dramatic increase in the number and size of vacuoles in NIH3T3 cells that was suppressed by the introduction of PIKfyve WTres but not of PIKfyve KEres (Fig. S4 , B and C), indicating that these shRNAs also reduce the expres sion of the endogenous proteins. To determine whether PIKfyve generates PtdIns(3,5)P 2 in response to glutamate, we introduced shPIKfyve into neurons, stimulated the cells with 50 µM glutamate, and measured PtdIns(3,5)P 2 production using the GFPGRAM protein. Introduction of shPIKfyve eliminated the relocalization of GFPGRAM to the perinuclear region, sug gesting that it also eliminated the production of PtdIns(3,5)P 2 (Fig. 5 G) . Interestingly, we observed relatively few vacuoles in most neurons expressing the shPIKfyve under resting condi tions, suggesting that PIKfyve activity is relatively low in rest ing neurons (Fig. S4 D) . Introduction of a PIKfyve WTres along with shPIKfyve restored the relocalization of the GRAM do main to the perinuclear region in response to glutamate, whereas the PIKfyve KEres domain did not rescue the effects of shPIK fyve on the localization of the GFPGRAM reporter. Together, these results provide evidence that activation of glutamate re ceptors leads to increases in PtdIns(3,5)P 2 levels in neurons and that this is mediated by PIKfyve.
PIKfyve regulates glutamate-dependent

Ca V 1.2 internalization and degradation
Because PIKfyve regulates endosome trafficking, we next inves tigated whether it contributes to the glutamatedependent inter nalization of Ca V 1.2 channels. We transfected neurons with shPIKfyve together with YFPHACa V 1.2 and measured the sur face levels of Ca V 1.2 after stimulation with glutamate. Knock down of PIKfyve significantly suppressed glutamatedependent Ca V 1.2 internalization (Fig. 6, A and B) , whereas a scrambled control shRNA (shScrambled) had no effect, suggesting that PIKfyve controls Ca V 1.2 levels on the cell surface. To determine whether PIKfyve also regulates degradation of endogenous Ca V 1.2, we introduced shPIKfyve into neurons and measured the amount of Ca V 1.2 channel in dendrites using antiCa V 1.2 anti bodies (Fig. 6, C and D) . shPIKfyve significantly decreased the deg radation of Ca V 1.2 in neurons treated with glutamate compared with shScrambled. Introduction of PIKfyve WTres restored the glutamatedependent degradation of Ca V 1.2, whereas PIKfyve KEres had no effect. Thus, PIKfyve seems to be required both for Ca V 1.2 internalization and degradation in response to increases in glutamate. Because the main product of PIKfyve is PtdIns(3,5)P 2 , we asked whether PtdInd(3,5)P 2 was necessary for glutamate induced Ca V 1.2 degradation. We overexpressed the phosphatase ANOVA). (E) Cortical neurons stained with anti-PtdIns(3,5)P 2 antibodies before and after treatment with 50 µM glutamate for 10 min. (F) Quantification of the data in D showing an increase in PtdIns(3,5)P 2 levels in perinuclear regions (n = 100; mean ± SEM; *, P < 0.0001 by Student's t test). (G) Change in perinuclear GFP-2× GRAM fluorescence in neurons containing either shPIKfyve or shScrambled along with either a control vector or PIKfyve WTres or PIKfyve KEres after treatment with 50 µM glutamate (n = 60 cells; 300 ROIs; mean ± SEM; *, P < 0.01 by one-way ANOVA). Bars, 10 µm. at least one other channel in addition to Ca V 1.2 but not for all cell surface channels.
Discussion
This study provides new insights into the mechanisms by which neurons are protected from excessive Ca 2+ influx and excito toxicity after excessive activation of NMDA receptors, such as what occurs during transient ischemic attacks, epileptic seizures, and in the penumbra of strokes. Our results suggest that neurons in ternalize Ca V 1.2 channels and AMPA receptors in response to sustained activation of glutamate receptors. This is followed by recruitment of PIKfyve to the early endosomes, probably by binding to the C terminus of Ca V 1.2 and to lipids that are en riched in the endosomal membrane. Recruitment of PIKfyve to the endosomes leads to an increase in PtdIns(3,5)P 2 levels in these vesicles, which promotes their maturation and eventual fusion with lysosomes and leads to Ca V 1.2 degradation (Fig. 8) . Thus, prolonged activation of NMDA receptors leads to both removal and degradation of Ca V 1.2 channels by a PIKfyve dependent mechanism.
This PIKfyvemediated degradation pathway seems to be essential for the ability of neurons to respond to moderate elevations of extracellular glutamate. Reducing PIKfyve or dis rupting PIKfyve's association with Ca V 1.2 channels prevents channel degradation and leads to cell death when neurons are stimulated with subtoxic concentrations of glutamate. Blocking LTCs and AMPA receptors blocks the increase in cell death in neurons lacking PIKfyve, indicating that these ion channels can be toxic even at moderate levels of excitability and need to be downregulated. The increased susceptibility of neurons to excitotoxicity in the absence of PIKfyve may help to explain why diseases that arise from mutations that alter PtdIns(3,5)P 2 levels disproportionately affect excitable cells such as neurons.
PtdIns(3,5)P 2 and membrane protein degradation in neurons
The important finding is that intracellular Ca 2+ elevations in mammalian neurons regulate the levels of PtdIns (3,5) (Matsumoto et al., 2002; Onishi et al., 2003) . Our data and these corroborating studies suggest that Ca 2+ regulation of PIKfyve activity might be a relatively ancient mechanism for cellular The observation that Ca 2+ influx through LTCs can con tribute to toxicity led us to ask whether one of the functions of PIKfyvedependent Ca V 1.2 degradation might be to reduce Ca 2+ dependent toxicity in neurons. To answer this question, we transfected neurons with either shScrambled or shPIKfyve and treated the cells with 50 µM glutamate for 10 min. 50 µM gluta mate for 10 min did not cause cell death in untransfected neu rons or neurons containing shScrambled (Fig. 7 C and Fig. S1 ). In contrast, treatment with glutamate caused a large increase in apoptosis in shPIKfyvecontaining neurons (Fig. 7, C and D) . The increase in glutamateinduced cell death in cells containing shPIKfyve was prevented by expression of PIKfyve WTres but not by PIKfyve KEres, indicating that the effects of shPIKfyve are specific and that the kinase activity of PIKfyve is required for its effect on survival. Together, these results strongly suggest that PIKfyve is important for protecting neurons from apoptosis under conditions of moderate glutamate receptor activation.
To determine whether PIKfyve protects neurons from excito toxicity by mediating internalization and degradation of Ca V 1.2 channels, we transfected neurons with shPIKfyve and treated them with 50 µM glutamate for 10 min in the presence or ab sence of the Ca V 1.2 blocker nimodipine. We found that blocking Ca V 1.2 channels protected 30% of the neurons lacking PIKfyve from glutamateinduced toxicity (Fig. 7 E) , suggesting that excess Ca 2+ entry through LTCs contributes to the increased sensitivity to glutamate in the absence of PIKfyve. Because AMPA receptors also contribute to excitotoxic cell death and these receptors are also known to be internalized in response to treatment of cells with glutamate, we investigated whether blocking AMPA receptors alone or in combination with LTCs prevented glutamateinduced cell death in neurons lacking PIKfyve. Blocking AMPA receptors expressing the shPIKfvye shRNA reduced cell death by 30%, whereas the combination of both LTC and AMPA blockers almost completely prevented cell death in neurons. This result argues that the susceptibility to glutamateinduced apoptosis in neurons lacking PIKfyve is caused by the activity of both LTCs and AMPA receptors (Fig. 7 F) .
This result also raised the interesting possibility that AMPA receptor internalization in response to glutamate might be mediated by PIKfyve. We examined this hypothesis by intro ducing into neurons one of the subunits of the AMPA recep tor, the GluR2 channel, tagged with an intracellular YFP and an extracellular HA tag. This construct was robustly internalized by treatment of neurons with 50 µM glutamate for 10 min. However, introduction of the PIKfyve shRNA completely pre vented GluR2 internalization, indicating that this event also depends on PIKfyve (Fig. S5, C-E) . In control experiments, we also tested the role of PIKfyve in regulating the internaliza tion of K V 1.2 channels but found that the surface expression of these channels did not depend on PIKfyve (Fig. S5, F and G) . Thus, PIKfyve seems to be important for the internalization of together with GFP, stimulated with glutamate, and immunostained with anti-Myc and anti-GFP antibodies. (F) The graph shows the percent decrease in the ratio of Ca V 1.2 to MAP2 fluorescence in dendrites in E (n = 100 dendrites; mean ± SEM; *, P < 0.005 by Student's t test). (G) Dendrites from neurons expressing Flag-Myc-Ca V 1.2 and LAMP-GFP in the presence or absence of shPIKfyve or shScrambled. Cells were stained with anti-Myc and anti-GFP antibodies before and after treatment with 50 µM glutamate for 15 min. (n = 5 neurons and 16-23 dendrites). The arrow shows Ca V 1.2 colocalization with the lysosomal marker LAMP-GFP. Bars: (A) 10 µm; (C, E, and G) 5 µm. Figure 7 . PIKfyve protects neurons against excitotoxic cell death. (A) Cortical neurons incubated with or without 10 µM MK801, 10 µM NBQX, 10 µM nimodipine (Nim), 0.5 µM agatoxin IVA (AgaIVA), 1 µM -conotoxin GVIA (Ctx), or 10 µM SNX482 (SNX) and stimulated with 50 µM glutamate (Glu) for 30 min and then incubated for 9.5 h before analysis. Arrows indicate typical pyknotic cells. (B) Pyknotic nuclei quantified for each condition in A (n = 3 and >500 cells/sample; mean ± SEM; *, P < 0.001; and **, P < 0.05 by one-way ANOVA). (C) Cortical neurons were stimulated with 50 µM glutamate for 10 min and then incubated for 10 h in the absence of glutamate. Representative images of neurons expressing DsRed and either shPIKfyve or shScrambled along with the PIKfyve WTres, PIKfyve KEres, or the corresponding empty vector are shown. Cells were stained with the nuclear dye Hoechst. (D) Cell death was measured by counting pyknotic nuclei (n = 3 and >50 cells/sample; mean ± SEM; *, P < 0.001 by one-way ANOVA). (E) Cortical neurons were stimulated with 50 µM glutamate for 10 min in the presence or absence of 10 µM nimodipine and then incubated for 10 h. Cell death was measured by counting pyknotic nuclei (n = 3 and >50 cells/sample; mean ± SEM; *, P < 0.001 by one-way ANOVA). (F) Cortical neurons treated as in E. When indicated, NBQX was added at a 10-µM concentration (mean ± SEM; *, P < 0.001 by one-way ANOVA). Bars: (A) 30 µm; (C) 10 µm. some aspects of the pathology observed in these patients could be caused by dysregulation of VGCCs or, more generally, by failure of activitydependent protein degradation. If this hypoth esis is correct, patients with PtdIns(3,5)P 2 phosphatase muta tions might benefit from the use of Ca 2+ channel blockers like gabapentin and pregabalin, which are widely used clinically for other applications.
In summary, our study identifies a novel mechanism for Ca 2+ channel degradation in neurons that integrates two unrelated fields, Ca 2+ channel signaling and endosomal trafficking. These experiments provide new insights into channel homeostasis and suggest a rationale for investigating Ca 2+ channel dysfunction in diseases caused by defects in PtdIns(3,5)P 2 signaling.
Materials and methods
Materials and antibodies
Lipofectamine 2000, terminal deoxynucleotidyl transferase, Fura-2 acetoxymethyl ester, and Hoechst 33258 were purchased from Invitrogen; MK801, NBQX, and nimodipine were purchased from Sigma-Aldrich; SNX482 was purchased from Alomone Labs; DL-AP3 was purchased from Tocris Bioscience; bafilomycin A1 and lactacystin were purchased from EMD; chloroquine was purchased from MP Biomedicals; biotin-deoxy-UTP was purchased from TriLink BioTechnologies; and fluorescein-conjugated streptavidin (DTAF-streptavidin) was purchased from Jackson ImmunoResearch Laboratories, Inc. Antibodies to Ca V 1.2 (1:500; AB5156; Millipore), PIKfyve (1:500; 6C7; Abnova), Myc (1:500; 4A6; Millipore), HA (3F10; Roche), Flag (1:500; M2; Sigma-Aldrich), GAPDH (1:1,000; 6C5; Applied Biosystems), or DsRed (1:500; E64-1077; BD) was used for immunoblot analysis. Antibodies to Ca V 1.2 (1:100; AB5156), MAP2 (1:500; MAB378; Millipore), Myc (1:500; 4A6), HA (1:500; 3F10), PtdIns(3,5)P 2 (1:100; Z-P035; Echelon), or GFP (1:500; 598; MBL) was used for immunocytochemistry.
Cell culture, stimulation, and transfection HEK 293T and NIH3T3 cells were cultured in Dulbecco's modified minimum essential medium containing 10% FBS, 100 U penicillin and 100 µg streptomycin (P/S), and 2 mM l-glutamine (Q). Neuro2A cells were cultured in minimum essential medium containing 10% FBS and P/S. Primary neuronal cultures were prepared from embryonic day 17-19 SpragueDawley rats by dissociating dissected cortices with enzyme solution (Hanks' balanced salt solution with 600 U papain and 0.32 mg/ml cystein). Neurons were plated on coverslips coated with 20 µg/ml polyornithine and 1.42 µg/ml laminin and maintained in culture in Basal Medium Eagle with protection, although this hypothesis clearly needs to be investi gated further in other systems.
Because PIKfyve seems to play a general role in the deg radation of a variety of cell surface proteins, it is interesting to speculate why it interacts with Ca V 1.2 channels. One possibil ity is that endosomes derived from Ca 2+ dependent endocyto sis in dendrites and synapses often contain Ca V 1.2 channels. By binding to Ca V 1.2, PIKfyve can be recruited to a specific type of activitydependent endosome and can play a role in the degradation of postsynaptic proteins. This is consistent with the general notion that the recruitment of proteins that contain FYVE domains to endosomal membranes is mediated by bind ing to both PtdIns(3)P and proteins located on endosomes (Simonsen et al., 1998; Lawe et al., 2000) . It will be interest ing to determine whether PIKfyve also participates in the Ca 2+ dependent degradation of other postsynaptic proteins such as NMDA receptors and whether this depends on PIKfyve bind ing to Ca V 1.2 channels.
Although PIKfyve has been reported to play a role in endosomal trafficking and lysosome function, it has not been shown to control endocytosis directly. We found that PIKfyve knockdown prevents Ca V 1.2 and AMPA receptor internalization in response to glutamate. This finding suggests either that PIKfyve can regulate the endocytic machinery directly or, alter natively, that altering endosome trafficking can prevent the activity or recycling of molecules required for endocytosis. The fact that we only observe PIKfyve in endosomes and not at the cell membrane argues that the effects of PIKfyve on endocyto sis are indirect, but this question will need to be studied more carefully in the future.
PtdIns(3,5)P 2 and disease
Our finding that PIKfyve interacts with Ca V 1.2 and regulates its degradation also has important implications for the pathology of several diseases that affect myocytes and neurons. These cells express large numbers of Ca V 1.2 channels, suggesting that Figure 8 . Model describing the process of Ca V 1.2 degradation in response to glutamate. Glutamate stimulation and high levels of intracellular Ca 2+ lead to channel degradation in a PIKfyve-dependent manner, which protects the cell from Ca 2+ toxicity. Stronger stimulation overrides this protective mechanism, and neurons undergo excitotoxicity.
TGATTCCTGG-3; LAMP1 forward, 5-AGGATCCGCCACCATGGCGGC-CCCCGGCAG-3; and reverse, 5-GGGATCCGATAGTCTGGTAGCC-TGCGTGACTCC-3; MTM1 forward, 5-AGGATCCGCCACCATGGCT-TCTGCATCAACTTC-3; and reverse, 5-AGGATCCTCAGAAGTGAGTT-TGCACATGGGG-3; 2× GRAM forward, 5-GGGATCCGCCACCATG-AAATATAATTCACACTCC-3; and reverse, 5-AGAATTCAGTAATATCTAG-ACCATAGGAATT-3; 2× GRAM forward, 5-AGAATTCATGAAATATAAT-TCACACTCCTTG-3; and reverse, 5-AGGATCCAGTAATATCTAGAC-CATAGGAATTTTCTCC-3; and GluR2 forward, 5-GTCTAGAGCCAC-CATGCAAAAGATTATGCATAT-3; and reverse, 5-GTCTAGAAATTTTA-ACACTTTCGATGCCATA-3.
The oligonucleotides used were as follows: mouse PIKfyve shRNA sense, 5-GATCCGGACAGGGTTGGATCTGAATTCAAGAGATT-CAGATCCAACCCTGTCCTTTTTTACGCGTG-3; and antisense, 5-AATT-CACGCGTAAAAAAGGACAGGGTTGGATCTGAATCTCTTGAATTCA-GATCCAACCCTGTCCG-3; rat PIKfyve shRNA sense, 5-GATCC-GGACAGGGTTGGATCTCAATTCAAGAGATTGAGATCCAACCCTGT-CCTTTTTTACGCGTG-3; and antisense, 5-AATTCACGCGTAAAAAAGGA-CAGGGTTGGATCTCAATCTCTTGAATTGAGATCCAACCCTGTCCG-3; and shScrambled shRNA sense, 5-GATCCTGTAGGTCGAGAGCGTAG-ATTCAAGAGATCTACGCTCTCGACCTACATTTTTTACGCGTG-3; and antisense, 5-AATTCACGCGTAAAAAATGTAGGTCGAGAGCGTAG-ATCTCTTGAATCTACGCTCTCGACCTACAG-3. RNAi-resistant PIKfyve cDNA was made by introducing silent mutations using conventional PCR. The PCR primers used were as follows: forward, 5-TCTAGAATGGCCA-CAGATGACAAGAGTTCCCCGACACTGGACTCTGCTAATGATTTG-3; and reverse, 5-TCTAGATTAGCAATTTAAGTCTAGTCCCGTCCAGTG-GTCTGGCACCATCAAGAAATACTT-3.
Immunocytochemistry
Cortical neurons plated on 12-or 15-mm coverslips and grown in 12-or 24-well plates were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. The coverslips were washed in PBS once and incubated with a blocking solution (5% BSA in PBS) with (for regular immunocytochemistry) or without (for surface expression assay) 0.4% Triton X-100 for 30 min. The samples were incubated with the indicated primary antibodies for 1 h at room temperature or overnight at 4°C and then washed three times in PBS at room temperature before incubation with secondary antibodies (Alexa Fluor 350 anti-mouse IgG [1:1,000], Alexa Fluor 488 anti-mouse/rabbit IgG [1:1,000], and/or Alexa Fluor 594 anti-mouse/ rabbit IgG [1:1,000]) for 30 min at room temperature in the blocking solution. For surface expression assays, the samples were incubated with anti-HA antibodies (3F10) for 1 h at room temperature or overnight at 4°C and then incubated with secondary antibodies (Alexa Fluor 594 anti-rat IgG [1:1000]) for 30 min at room temperature in the blocking solution. Cells were imaged using an epifluorescence microscope (TE2000U; Nikon) equipped with 10× S Fluor 0.5 NA (Nikon), 40× S Fluor 1.30 NA (Nikon), and 60× Plan-Apochromat 1.40 NA (Nikon) objective lenses and a cooled charge-coupled device camera (ORCA-ER; Hamamatsu Photonics) controlled by a computer (Macintosh; Apple) running Open Laboratory software (PerkinElmer).
Image analysis
To measure the surface expression levels, the single regions were defined to encompass the entire cell body and calculate the ratio of HA to YFP fluorescence. To measure the relocalization of the GFP-2× GRAM in neurons, fluorescent images were obtained and analyzed using Open Laboratory software. For each cell, five circular regions of interest (ROIs) were defined around the periphery of the cell nucleus, and a single ROI was defined to encompass the entire cell body. The mean fluorescence intensity calculated from the ROIs around the nucleus was divided by the mean intensity of the entire cell body to generate a perinuclear ratio value (P). The percent change in P in stimulated cells was calculated using the following equation: %P = (P S  P R )/P R , where P S is the ratio after stimulation and P R is the ratio in resting cells. Stimulation of cells with glutamate resulted in an increase in puncta that could be detected using the anti-PtdIns(3,5)P 2 antibodies. To quantify the number of puncta, the raw fluorescence images were intensity sliced to generate binary images that included only pixels that were part of a puncta. The area covered by the puncta was divided by the total area of the cell to generate a value for the percentage of pixels in a cell that formed part of a puncta. Colocalization of Flag-Myc-Ca V 1.2 and LAMP-GFP was evaluated by using line profiles drawn along neuronal dendrites for each type of staining using Igor Pro software (WaveMetrics). The coefficient of correlation between the Flag-Myc-Ca V 1.2 and LAMP-GFP line profiles was calculated according to the following equation: 45 min at 37°C. The samples were then incubated in a solution (10 µM Hoechst 33258 in PBS) for 10 min to stain the nuclei.
Online supplemental material Fig. S1 shows that glutamate stimulation promotes neuronal cell death. Fig. S2 shows that glutamate stimulation promotes Ca V 1.2 relocalization and degradation. Fig. S3 shows localization of LAMP, PIKfyve, and the GRAM domain. Fig. S4 shows that knockdown of PIKfyve by PIKfyve shRNAs promotes vacuole formation. Fig. S5 shows that PIKfyve is important for specific channel internalization and degradation. Table S1 lists Ca V 1.2-interacting proteins. Online supplemental material is available at http://www .jcb.org/cgi/content/full/jcb.200903028/DC1.
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Immunoblot analysis Cells were washed with PBS and then lysed in extraction buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EGTA, 5 µM NaF, 1 µM Na 3 VO 4 , 0.5% Triton X-100, and 1 mM dithiothreitol) containing a protease inhibitor cocktail tablet (Roche). The cell lysates were analyzed by SDS-PAGE, transferred to polyvinylidene fluoride, probed with primary antibodies, and detected with HRP-conjugated secondary antibodies and luminol reagent (SuperSignal West Dura Extended Duration Substrate; Thermo Fisher Scientific).
Coimmunoprecipitation
Transfected HEK 293T cells were washed with PBS and then lysed in extraction buffer containing protease inhibitors (see Immunoblot analysis). The cell lysates were centrifuged at 13,200 rpm for 10 min, and the resulting supernatant was subjected to immunoprecipitation with antibodies to 10 µg/ml PIKfyve (6C7), 2.5 µg/ml Myc (4A6), or anti-Flag M2 agarose beads (Sigma-Aldrich) for 3 h at 4°C. The immunoprecipitates were subjected to immunoblot analysis with antibodies to Ca V 1.2, Myc, Flag, and HA.
Proteomics and mass spectrometry
The protein complex associated with the C terminus of Ca V 1.2 was purified and analyzed using mass spectrometry three independent times. One immunoprecipitated sample was analyzed in duplicate to generate a total of five mass spectrometry data samples. For each experiment, three 10-cm plates of Neuro2A cells were transfected with GST-YFP or with GST-Ca V 1.2 CT using Lipofectamine 2000 according to the manufacturer's instructions (24 µg DNA/plate in 1.5 ml of Opti-MEM-I and 60 µl of Lipofectamine in 1.5 ml of Opti-MEM-I). 2 d after transfection, the cells were lysed in lysis buffer (50 mM Tris-HCl, 1% Triton X-100, 150 mM NaCl, and 10 mM EDTA) for 30 min at 4°C with shaking. The lysis buffer was supplemented with an inhibitor cocktail tablet (Roche) and calpain I and II inhibitors. The lysates were centrifuged for 20 min at 14,000 rpm and incubated with 100 µl of glutathione Sepharose beads (GE Healthcare) for 2 h at 4°C. The beads were washed five times in lysis buffer and treated with trypsin before analysis. The peptides were separated using capillary electrophoresis and analyzed by tandem mass spectrometry in the Stanford University Mass Spectrometry facility. Finally, all of the peptide sequences were analyzed using MASCOT software (Matrix Science).
Ca 2+ imaging Cortical neurons were loaded with 1 µM Fura-2 for 30 min at 37°C in Tyrode's solution (129 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 30 mM glucose, 0.1% BSA, and 25 mM Hepes, pH 7.4), washed with Tyrode's solution, and placed in a perfusion chamber on the stage of an inverted fluorescence microscope (TE2000U; Nikon). The cells were treated with 50 µM glutamate in Tyrode's solution without Mg (129 mM NaCl, 5 mM KCl, 3 mM CaCl 2 , 30 mM glucose, 0.1% BSA, and 25 mM Hepe, pH 7.4) for 10 min before imaging in normal Tyrode's solution and then stimulated with high KCl Tyrode's solution (67 mM NaCl, 67 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 30 mM glucose, 0.1% BSA, and 25 mM Hepes, pH 7.4). Imaging was performed at room temperature on an epifluorescence microscope (Eclipse TE2000U; Nikon) equipped with an excitation wheel and an automated stage. Open Laboratory software was used to collect and quantify time-lapse excitation ratio images. Fluorescence images were analyzed using Igor Pro software.
Cell death assay
Cortical neurons were stimulated with 50 µM glutamate for the indicated times and were then incubated for 10 h in the absence of glutamate. Neurons were then fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. The coverslips were incubated in a solution (10 µM Hoechst 33258 and 0.4% Triton X-100 in PBS) for 10 min to stain the nuclei. Fluorescence images were obtained by epifluorescence microscopy, and pyknotic nuclei were counted. For TUNEL assay, neurons were fixed with 4% paraformaldehyde in PBS for 15 min at room temperature and incubated with 0.1% Triton X-100 in PBS for 10 min. The samples were then incubated with TUNEL reaction solution (15 U terminal deoxynucleotidyl transferase, 40 µM biotin-deoxy-UTP, 0.1 M potassium cacodylate, 2 mM CoCl 2 , and 0.2 mM DTT) for 1 h at 37°C and washed three times in PBS at room temperature before incubation with DTAF-streptavidin (1:800) for
